230 related articles for article (PubMed ID: 29935594)
1. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies.
Yap A; Lopez-Olivo MA; Dubowitz J; Pratt G; Hiller J; Gottumukkala V; Sloan E; Riedel B; Schier R
Br J Anaesth; 2018 Jul; 121(1):45-57. PubMed ID: 29935594
[TBL] [Abstract][Full Text] [Related]
2. Perioperative beta-blocker use and survival in lung cancer patients.
Cata JP; Villarreal J; Keerty D; Thakar DR; Liu DD; Sood AK; Gottumukkala V
J Clin Anesth; 2014 Mar; 26(2):106-17. PubMed ID: 24480297
[TBL] [Abstract][Full Text] [Related]
3. Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis.
Caparica R; Bruzzone M; Agostinetto E; De Angelis C; Fêde Â; Ceppi M; de Azambuja E
ESMO Open; 2021 Apr; 6(2):100066. PubMed ID: 33639601
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the effects of beta blocker on survival time in cancer patients.
Choi CH; Song T; Kim TH; Choi JK; Park JY; Yoon A; Lee YY; Kim TJ; Bae DS; Lee JW; Kim BG
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1179-88. PubMed ID: 24671228
[TBL] [Abstract][Full Text] [Related]
5. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
Wang HM; Liao ZX; Komaki R; Welsh JW; O'Reilly MS; Chang JY; Zhuang Y; Levy LB; Lu C; Gomez DR
Ann Oncol; 2013 May; 24(5):1312-9. PubMed ID: 23300016
[TBL] [Abstract][Full Text] [Related]
6. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
[TBL] [Abstract][Full Text] [Related]
7. Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.
Chen HY; Zhao W; Na'ara S; Gleber-Netto FO; Xie T; Ali S; Thompson ZM; Buell J; Stafford H; Nagarajan P; Davies M; Wong MK; Migden MR; Sharma P; Myers JN; Gross ND; Amit M
JCO Precis Oncol; 2023 Jun; 7():e2200490. PubMed ID: 37285560
[TBL] [Abstract][Full Text] [Related]
8. Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death.
De Giorgi V; Gandini S; Grazzini M; Benemei S; Marchionni N; Geppetti P
Mayo Clin Proc; 2013 Nov; 88(11):1196-203. PubMed ID: 24182700
[TBL] [Abstract][Full Text] [Related]
9. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.
Watkins JL; Thaker PH; Nick AM; Ramondetta LM; Kumar S; Urbauer DL; Matsuo K; Squires KC; Coleman RL; Lutgendorf SK; Ramirez PT; Sood AK
Cancer; 2015 Oct; 121(19):3444-51. PubMed ID: 26301456
[TBL] [Abstract][Full Text] [Related]
11. β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis.
Childers WK; Hollenbeak CS; Cheriyath P
Clin Breast Cancer; 2015 Dec; 15(6):426-31. PubMed ID: 26516037
[TBL] [Abstract][Full Text] [Related]
12. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
Deng XF; Liu QX; Zhou D; Min JX; Dai JG
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
15. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
16. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
[TBL] [Abstract][Full Text] [Related]
17. Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis.
Chen Y; Jiang L; Gao B; Cheng ZY; Jin J; Yang KH
Breast Cancer Res Treat; 2016 Jun; 157(3):517-25. PubMed ID: 27246814
[TBL] [Abstract][Full Text] [Related]
18. The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis.
Song T; Choi CH; Kim MK; Kim ML; Yun BS; Seong SJ
Eur J Cancer Prev; 2017 Jan; 26(1):78-85. PubMed ID: 27158979
[TBL] [Abstract][Full Text] [Related]
19. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
Li X; Xu S; Tan Y; Chen J
Cochrane Database Syst Rev; 2015 Jun; (6):CD010432. PubMed ID: 26037486
[TBL] [Abstract][Full Text] [Related]
20. Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapy.
Wang H; Liao Z; Zhuang Y; Liu Y; Levy LB; Xu T; Yusuf SW; Gomez DR
Clin Lung Cancer; 2015 Mar; 16(2):128-36. PubMed ID: 25450873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
